menu search

Cerevance announces presentation at the 22nd society of chemical industry / royal society of chemistry medicinal chemistry symposium

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel, pre...

August 31, 2023, 12:30 pm

Uk car production surges 31.6% on strong export demand: smmt

UK car production rose for the sixth successive month in July amid strong demand from the foreign market and a recent recovery in the global supply ch...

August 31, 2023, 9:31 am

Uk car production rose for the sixth consecutive month in july

The society of Motor Manufacturers and Traders (SMMT) in the UK said a total of 76,451 units rolled out...

August 31, 2023, 12:05 am

3 up-and-coming ai chip stocks to put on your must-buy list

Are you searching for a list of top AI chip companies? AI chip companies are set to soar in the coming decade, with the undeniable disruption of techn...

August 30, 2023, 3:13 pm

Perspective therapeutics to present at the world molecular imaging congress 2023

RICHLAND, WASH. & CORALVILLE, IOWA, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Perspective T h erapeutics, Inc.  (“Perspective” or “the Company”) (NYS...

August 30, 2023, 8:17 am

Eagle pharmaceuticals to present byfavo® (remimazolam) for injection abstract at prestigious society for neuroscience in anesthesiology and critical care (snacc) conference

-- Abstract compares relative effects on cognitive function following sedation with Byfavo (remimazolam) for injection versus midazolam -- Abstract co...

August 30, 2023, 6:50 am

Amicus therapeutics announces presentation and posters at the ssiem annual symposium 2023

PHILADELPHIA, Aug. 29, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced that one oral presentation and five posters acros...

August 29, 2023, 11:00 am

Pliant therapeutics announces three upcoming presentations at the european respiratory society international congress 2023

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focus...

August 28, 2023, 8:05 pm

Aiche awards its 2023 langer prize fellowship to albert j. keung of north carolina state university

Grant from chemical engineering society will support research on the data-storage potential of DNA NEW ...

August 28, 2023, 11:00 am

Praxis precision medicines to present analyses of patient-focused, clinically meaningful endpoints from essential1 study of ulixacaltamide in essential tremor at the 2023 mds international congress

BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...

August 28, 2023, 7:00 am

Former home depot ceo ‘fears' biden administration is ‘fueling a lawless society' as retail left surges

Former Home Depot CEO Bob Nardelli discusses the impact of surging crime and theft on retailers as well as American consumers across the country....

August 28, 2023, 6:11 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am

Bridgebio presents detailed positive results from phase 3 attribute-cm study of acoramidis for patients with transthyretin amyloid cardiomyopathy (attr-cm) at european society of cardiology congress 2

– The primary endpoint was met (Win Ratio of 1.8) with a highly statistically significant p-value (p<0.0001); this primary endpoint result consisten...

August 27, 2023, 10:15 am

Esperion presents two clear outcomes study late-breakers at european society of cardiology congress 2023

– In total cardiovascular event analysis, bempedoic acid shows 20% risk reduction in MACE-4 and 17% risk reduction in MACE-3 – – In an analysis ...

August 26, 2023, 3:00 pm

Travere therapeutics to present abstracts at the society for the study of inborn errors of metabolism annual symposium 2023

SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present clinical data fr...

August 24, 2023, 8:30 pm

Travere therapeutics to present abstracts at the society for the study of inborn errors of metabolism annual symposium 2023

SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present clinical data fro...

August 24, 2023, 4:30 pm

Utf: a look at this 8.2% yielding infrastructure closed end fund

Cohen and Steers Infrastructure Fund invests in infrastructure companies, which provide the physical framework for ...

August 24, 2023, 4:17 pm


Search within

Pages Search Results: